NCT04605081View on ClinicalTrials.gov

Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 10, 2022

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Loss-of-Control EatingObesity/Overweight
Interventions
DRUG

Naltrexone and Bupropion (NB) medication

NB medication will be taken daily in pill form.

OTHER

Placebo

Placebo will be inactive and taken daily in pill form.

Trial Locations (1)

06510

Yale School of Medicine, New Haven

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER